US Patent 10563179 Compositions and methods for antigen targeting to CD180
Patent 10563179 was granted and assigned to University of Washington on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+172 characters)
Article
Patent abstract
The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105631790
Date of Patent
February 18, 2020
0Patent Application Number
162454590
Date Filed
January 11, 2019
0Patent Citations Received
Patent Primary Examiner
Edits on 11 Jan, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105631790
Date of Patent
February 18, 2020
0Patent Application Number
162454590
Date Filed
January 11, 2019
0Patent Citations Received
Patent Primary Examiner
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10563179 Compositions and methods for antigen targeting to CD180
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10563179
Date of patent
February 18, 2020
Patent application number
16245459
Date Filed
January 11, 2019
Patent primary examiner
Find more entities like US Patent 10563179 Compositions and methods for antigen targeting to CD180
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
